Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5208)
All Articles published online
|
Publishing Process of This Article
|
Jan 28, 2024 (publication date) through Mar 31, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Li YJ, Baumert BO, Stratakis N, Goodrich JA, Wu HT, He JX, Zhao YQ, Aung MT, Wang HX, Eckel SP, Walker DI, Valvi D, La Merrill MA, Ryder JR, Inge TH, Jenkins T, Sisley S, Kohli R, Xanthakos SA, Baccarelli AA, McConnell R, Conti DV, Chatzi L. Circulating microRNA expression and nonalcoholic fatty liver disease in adolescents with severe obesity. World J Gastroenterol 2024; 30(4): 332-345 [PMID: 38313232 DOI: 10.3748/wjg.v30.i4.332] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v30/i4/332.htm |
| Number | Citing Articles |
| 1 |
Shaza H. Aly, Ahmed I. Abulsoud, Yasser M. Moustafa, Sherif S. Abdel Mageed, Nourhan M. Abdelmaksoud, Walaa A. El-Dakroury, Osama A. Mohammed, Mustafa Ahmed Abdel-Reheim, Mohamed Bakr Zaki, Nehal I. Rizk, Ahmed Elshafei, Hanan Elimam, Alaa Ashraf, Ahmed S. Doghish. Harnessing natural compounds to modulate miRNAs in breast cancer therapy. Functional & Integrative Genomics 2024; 24(6) doi: 10.1007/s10142-024-01489-7
|
| 2 |
Reda M. Mansour, Sherif S. Abdel Mageed, Ahmed I. Abulsoud, Ghadir A Sayed, Radwa H. Lutfy, Farah A. Awad, Mohamed M. Sadek, Abanoub A. S. Shaker, Osama A. Mohammed, Mustafa Ahmed Abdel-Reheim, Hanan Elimam, Ahmed S. Doghish. From fatty liver to fibrosis: the impact of miRNAs on NAFLD and NASH. Functional & Integrative Genomics 2025; 25(1) doi: 10.1007/s10142-025-01544-x
|
| 3 |
Haidong He, Yifan Zhu, Xiaoguo Ji, Suying Pu, Hui Zheng. The miR-22–5p/Clec4e axis has diagnostic potential in fructose-induced nonalcoholic fatty liver disease. Biochemical and Biophysical Research Communications 2025; 753: 151496 doi: 10.1016/j.bbrc.2025.151496
|
| 4 |
Zhiping Wan, Xiaoquan Liu, Xiaoan Yang, Zexuan Huang, Xiaoman Chen, Qingqing Feng, Hong Cao, Hong Deng. MicroRNA-411-5p alleviates lipid deposition in metabolic dysfunction-associated steatotic liver disease by targeting the EIF4G2/FOXO3 axis. Cellular and Molecular Life Sciences 2024; 81(1) doi: 10.1007/s00018-024-05434-6
|
| 5 |
Francesco Colaianni, Veronica Zelli, Chiara Compagnoni, Martina Sara Miscione, Mario Rossi, Davide Vecchiotti, Monica Di Padova, Edoardo Alesse, Francesca Zazzeroni, Alessandra Tessitore. Role of Circulating microRNAs in Liver Disease and HCC: Focus on miR-122. Genes 2024; 15(10): 1313 doi: 10.3390/genes15101313
|